NDC 75936-628-01 - ProtecTINT 20C
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 75936-628
- Requested NDC
- 75936-628-01
- Package NDCs from labels
- 75936-628-01, 75936-628-02
- Manufacturer
- Supergoop, LLC
- Effective date
- 2025-10-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ProtecTINT 20C - Supergoop, LLC | Supergoop, LLC | 2025-10-07 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 75936-628-02 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9571-d83d-e063-dadaa90ab31f | Protec(tint) SPF 50 |
| 75936-628-02 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9571-d83d-e063-dadaa90ab31f | Protec(tint) SPF 50 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 75936-628-01 | ProtecTINT 26W | 35 mL in 1 TUBE | CREAM | 35 | 2 | |
| 75936-628-02 | ProtecTINT 26W | 1 in 1 BOX | CREAM | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 75936-628 | PROTECTINT 20C (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 26W (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 32N (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 34C (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 58W (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 10N (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 24N (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 22W (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 30W (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 46N (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 42C (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 52N (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 14N (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM PROTECTINT 40W (HOMOSALATE, OCTISALATE, ZINC OXIDE) CREAM [SUPERGOOP, LLC] | 1 | Current NDC, 2 package rows | 20231129_0801287f-0df5-4303-e063-6394a90a503b.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ESTEE LAUDER DOUBLE WEAR SHEER LONG-WEAR MAKEUP BROAD SPECTRUM SPF 19 | OCTINOXATE AND TITANIUM DIOXIDE | ESTEE LAUDER INC | 2f93580c-c8e9-4822-91bf-a749cf4deb4e | 2024-12-25 | Warnings | M020 15FIX9V2JP |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b14a17-cab9-1b3e-e063-6394a90afe5d | 2024-12-25 | Warnings | M020 V06SV4M95S SOI2LOH54Z 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 06ab109e-abcf-0861-e063-6394a90a9375 | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 0d3379ba-465d-a889-e063-6394a90aaf23 | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 0d339273-6d82-0979-e063-6394a90a3de7 | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 0cc97b34-e9e6-ef6a-e063-6394a90aee89 | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 0cc9760b-b88b-f291-e063-6294a90a242f | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 0d338ec2-dca0-e032-e063-6394a90a69aa | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 0752d79d-5d82-0367-e063-6394a90a4f1c | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 0d33888d-20b3-f912-e063-6394a90a25dc | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 0d3379ba-465c-a889-e063-6394a90aaf23 | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b25290-33a0-bafd-e063-6394a90a7a94 | 2024-12-25 | Warnings | M020 V06SV4M95S SOI2LOH54Z 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 0751b356-607f-f3cb-e063-6294a90a4092 | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b14a17-cace-1b3e-e063-6394a90afe5d | 2024-12-25 | Warnings | M020 V06SV4M95S SOI2LOH54Z 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 07530636-cd21-3022-e063-6394a90a89d6 | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Leg Body Makeup | OCTISALATE, OCTOCRYLENE | COSMAX USA, CORPORATION | 0752753e-cac9-9166-e063-6394a90a4d8d | 2024-12-25 | Warnings | M020 4X49Y0596W |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06ad3c09-9f1b-b25c-e063-6294a90aebe1 | 2024-12-25 | Warnings | M020 V06SV4M95S SOI2LOH54Z 4X49Y0596W |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c57ff5-7013-d35f-e063-6394a90a6ee2 | 2024-12-25 | Warnings | M020 V06SV4M95S SOI2LOH54Z 4X49Y0596W |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b1f8bc-8b29-451a-e063-6294a90a34bd | 2024-12-25 | Warnings | M020 V06SV4M95S SOI2LOH54Z 4X49Y0596W |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b26dd0-44de-91a7-e063-6394a90a603a | 2024-12-25 | Warnings | M020 V06SV4M95S SOI2LOH54Z 4X49Y0596W |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.